Dagmara Kisiela

Title: Dagmara Kisiela: Innovator in Uropathogenic Infection Treatment

Introduction

Dagmara Kisiela is a prominent inventor based in Seattle, WA (US). She has made significant contributions to the field of medical research, particularly in the treatment and prevention of uropathogenic infections. Her innovative work has the potential to impact the way bacterial infections are managed.

Latest Patents

Dagmara Kisiela holds a patent for "Compositions and methods for treatment and prevention of uropathogenic infection." This patent describes methods and antibody compositions that displace mannose from the binding pocket of fimbrial adhesin FimH of enterobacteria. The invention can disrupt or prevent the attachment of bacteria to surfaces and inhibit the formation of biofilms. The antibody compositions can be utilized to prevent infections caused by enterobacteria, treat bacterial infections, and address inflammatory bowel disease (IBD), among other applications.

Career Highlights

Kisiela is affiliated with the University of Washington, where she continues her research and development efforts. Her work is characterized by a commitment to advancing medical science and improving patient outcomes through innovative solutions.

Collaborations

Some of her notable coworkers include Evgeni V Sokurenko and Wendy Evelyn Thomas. Their collaborative efforts contribute to the ongoing research and development in the field of uropathogenic infections.

Conclusion

Dagmara Kisiela's contributions to the treatment of uropathogenic infections highlight her role as an influential inventor in the medical field. Her innovative approaches and dedication to research continue to pave the way for advancements in healthcare.